Incidence of increased plasminogen activator inhibitor in patients with deep venous thrombosis and/or pulmonary embolism.

Suppr

超能文献

作者信息

Tabernero M D, Estellés A, Vicente V, Alberca I, Aznar J

机构信息

Hematology Unit, University Hospital, Salamanca, Spain.

出版信息

Thromb Res. 1989 Nov 15;56(4):565-70. doi: 10.1016/0049-3848(89)90242-9.

DOI:10.1016/0049-3848(89)90242-9

PMID:2609293

Abstract

摘要

相似文献

Incidence of increased plasminogen activator inhibitor in patients with deep venous thrombosis and/or pulmonary embolism.

Thromb Res. 1989 Nov 15;56(4):565-70. doi: 10.1016/0049-3848(89)90242-9.

Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.有特发性深静脉血栓形成和/或肺栓塞病史患者的纤溶功能减退。

Thromb Haemost. 1992 Apr 2;67(4):397-401.

Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.基线纤维蛋白溶解状态与未来静脉血栓形成风险。内源性组织型纤溶酶原激活物和纤溶酶原激活物抑制剂的前瞻性研究。

Circulation. 1992 May;85(5):1822-7. doi: 10.1161/01.cir.85.5.1822.

Postoperative deep vein thrombosis and plasma levels of tissue plasminogen activator inhibitor.

Thromb Res. 1990 Nov 1;60(3):247-51. doi: 10.1016/0049-3848(90)90187-h.

Deficient tissue plasminogen activator release and normal tissue plasminogen activator inhibitor in a patient with recurrent deep vein thrombosis.一名复发性深静脉血栓形成患者存在组织型纤溶酶原激活物释放不足及组织型纤溶酶原激活物抑制剂正常的情况。

Am J Med. 1990 Feb;88(2):199-200. doi: 10.1016/0002-9343(90)90478-v.

[Disorders of the liberation of tissue-type plasminogen activator (t-PA) from the venous wall as a cause for recurrent thromboses].

Vasa Suppl. 1993;39:5-10.

D-dimer levels correlate with pathologic thrombosis in trauma patients.

J Trauma. 1992 Aug;33(2):312-9; discussion 319-20. doi: 10.1097/00005373-199208000-00023.

[D-dimer determination in suspected deep venous thrombosis or lung embolism].[疑似深静脉血栓形成或肺栓塞时的D-二聚体测定]

Praxis (Bern 1994). 1997 Nov 19;86(47):1860-4.

Absence of antibodies to tissue-type plasminogen activator in patients with previous deep vein thrombosis.

Int J Clin Lab Res. 1998;28(1):72-3. doi: 10.1007/s005990050020.

Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release.

Thromb Haemost. 1991 Oct 1;66(4):426-9.

引用本文的文献

Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.纤溶酶原激活物抑制剂-1（PAI-1）：连接纤维蛋白溶解和与年龄相关的亚临床及临床状况的关键因素。

Cardiovasc Ther. 2010 Oct;28(5):e72-91. doi: 10.1111/j.1755-5922.2010.00171.x. Epub 2010 Jul 7.

Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease.1型纤溶酶原激活物抑制剂（第一部分）：基本机制、调节及其在血栓栓塞性疾病中的作用

J Thromb Thrombolysis. 2001 May;11(3):183-93. doi: 10.1023/a:1011955018052.

Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.在内毒素处理小鼠的组织中，纤维蛋白沉积与尿激酶型纤溶酶原激活物而非组织型纤溶酶原激活物表达的降低相关。

J Clin Invest. 1996 Jun 1;97(11):2440-51. doi: 10.1172/JCI118691.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验